Chaichian Shahla, Nikfar Banafsheh, Arbabi Bidgoli Sepideh, Moazzami Bahram
Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.
Pars Advanced and Minimally Invasive Medical Manners Research Center, Pars Hospital, Iran University of Medical Sciences, Tehran, Iran.
Curr Med Chem. 2025;32(1):74-86. doi: 10.2174/0109298673269733230921092509.
Endometrial glands and stroma can be seen outside the uterine cavity in endometriosis, a gynecological disorder linked to estrogen dependency. Hormonal therapies, surgical excision, and non-steroidal anti-inflammatory drug therapy are among the traditional endometriosis treatments, however, various side effects limit their efficacy. Therefore, it is vital to research complementary and alternative therapeutic modalities to decrease the side effects of conventional therapies. While the search for the best endometriosis treatment continues, the focus is being paid to the assistance provided by polyphenols, notably quercetin. A broad spectrum of health-improving benefits of quercetin includes interactions with endometriosis-related molecular targets such as cell proliferation, apoptosis, invasiveness, inflammation, and oxidative stress. According to already-known research, medicines that mimic the physiological effects of quercetin are good candidates for creating novel endometriosis therapies. This review aims to comprehensively review quercetin's potential as a non-pharmacological treatment for endometriosis by interacting with several cellular and molecular targets.
子宫内膜异位症是一种与雌激素依赖性相关的妇科疾病,在子宫腔外可见子宫内膜腺体和间质。激素疗法、手术切除和非甾体抗炎药疗法是传统的子宫内膜异位症治疗方法,然而,各种副作用限制了它们的疗效。因此,研究补充和替代治疗方式以减少传统疗法的副作用至关重要。在继续寻找最佳子宫内膜异位症治疗方法的同时,人们将重点放在了多酚尤其是槲皮素提供的帮助上。槲皮素具有广泛的健康改善益处,包括与子宫内膜异位症相关的分子靶点如细胞增殖、凋亡、侵袭、炎症和氧化应激相互作用。根据已知研究,模拟槲皮素生理效应的药物是开发新型子宫内膜异位症疗法的良好候选药物。本综述旨在通过与多个细胞和分子靶点相互作用,全面综述槲皮素作为子宫内膜异位症非药物治疗的潜力。